$1.42+1.43%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →In8bio last closed at $1.42 (+1.43%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -1.5×. Its overall grade ranks 488 of 741 stocks in Healthcare.
About this company
In8bio last closed at $1.42 (+1.43%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 488/741
Valuation grade B
Related stocks
- Bristol Myers SquibbCustomer
세포치료제 공동개발 및 파이프라인 협력 가능성이 있는 대형 제약사
- AstraZenecaCustomer
면역항암·세포치료 분야에서 협력 대상이 될 수 있는 글로벌 제약사
- NovartisCustomer
세포치료 및 항암 파이프라인의 잠재적 라이선스·협력 고객
About In8bio
- What technical signals does In8bio (INAB) have?
- In8bio current technical signals: no active technical signal.
- Is In8bio a cup-and-handle pattern?
- No. In8bio has no valid Cup signal right now.
- What published figures are available for In8bio?
- Market cap: $6.58M. Trailing 12 months PER: -1.5×. Latest quarter PBR: 1.51×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about In8bio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy